Nr 546 nr546 week 8 - Study guides, Class notes & Summaries

Final Exam: NR546/ NR 546 (NEW Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review| Complete Guide with Questions and Verified Answers| 100% Correct- Chamberlain QUESTION MAOI use LAST choice for depression because of many potential, serious s/e QUESTION MAOI mech of action Answer: block enzymes responsible for the breakdown of 5HT, NE, DA - 2 primary forms of MAOI enzyme (MAOI-A and MAOI-B) -both are located in brain ...

Final Exam: NR546 / NR 546 (Latest Update 2024 / 2025) Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Guide | Weeks 5 - 8 Covered | Questions and Verified Answer s| 100% Correct - Chamberlain Q: Medication Management SSRI-Selective Serotonin Reuptake Inhibitors *Inhibit 5 HT reuptake SNRI-Serotonin Norepinephrine Reuptake Inhibitors *inhibit 5-HT reuptake *inhibit NE reuptake (increase energy, focus) *increase DA in prefrontal cortex (increase cogni...

Midterm Exam: NR546/ NR 546 (Latest Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Guide |Weeks 1-4 Covered| Questions and Verified Answers| 100% Correct- Chamberlain Q: FGA side effects hyperprolactinemia, extrapyramidal symptom (EPS), QT pro- longation, tornadoes de pointes, blood dyscrasias, sedation, orthostatic hypoten- sion, dizziness. Q: Clozapine Answer: not indicated for use in acute presentation of schizophrenia, ab- solute n...

Final Exam: NR546/ NR 546 (Latest Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Guide |Weeks 5-8 Covered| Questions and Verified Answers| 100% Correct- Chamberlain Q: Medication Management SSRI-Selective Serotonin Reuptake Inhibitors *Inhibit 5 HT reuptake SNRI-Serotonin Norepinephrine Reuptake Inhibitors *inhibit 5-HT reuptake *inhibit NE reuptake (increase energy, focus) *increase DA in prefrontal cortex (increase cognition) NDRI-Norepine...

NR 546 / NR546 Neurotransmitter Table * To be completed throughout course and submitted in Week 8* 2023/2024

Neuro transmitter Receptor Subtype Location/Function/Effects /symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA α-Amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) mediate the majority of fast excitatory synaptic transmission in the brain. AMPA receptors ...

NR 546 Week 8 Neurotransmitter Table Chamberlain. Neuro transmitter Receptor Subtype Location/Function/Effects /symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA α-Amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) mediate the majority of fast excitatory syn...

NR 546 Week 8 Neurotransmitter Table Chamberlain College Of Nursing. MNDA N-methyl-D-aspartate (NMDA) receptors represent one of the ligand-gated non-selective ionotropic glutamate receptors (iGluRs), which CNS NMDA receptors are found in both synaptic and extrasynaptic NDMA Glutamate Antagonist NDMA Glutamate AntagonistMemantine Phencyclidine Ketamine Dextromethorphan Dextromethadone are present in high density within the hippocampus and the cerebral cortex N-methyl-D-aspa...